Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

ATYR0101

Source date not recordedAnalyse record ↗

Preclinical fusion protein designed to bind extracellular-matrix LTBP-1 and selectively promote apoptosis of activated myofibroblasts that drive pathological fibrosis.

Modality
DARS-derived Fc fusion protein
Availability (US)
Preclinical development
Biomarkers
LTBP-1 binding; activated myofibroblast apoptosis; collagen deposition; alpha-SMA; inflammatory cytokines
Hallmark targeted
extracellular-matrix dysregulation, chronic inflammation, fibrotic cell accumulation
Kind
investigational biologic